Saturday 17 October 2026
Export PLUR’s income statement to Excel — free account
Pluri Inc.
PLUR Healthcare Biotechnology
Pluri Inc.’s revenue for fiscal 2026 (year ended June 2026) was $1.0 million, down 24.0% from fiscal 2025. In the quarter to June 2026, revenue fell 15.8%, EPS grew 48.0%, free cash flow grew 25.0% and total debt rose 3.43%, each against the same quarter a year earlier.
0.93
0.01
−1.06%
Follow PLUR
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | — | — | — | 4 | 3 | 1 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 45.69 | 699.65 | 2,089.09 | — | 128.98 | 102.18 | 92.58 | 23.48 | 20.04 |
Altman Z-Score |
— | (2.47) | (9.43) | 3.51 | — | (8.09) | (11.44) | (15.39) | (17.73) | (30.41) |
Altman Z″-Score (non-manufacturers) |
— | (17.05) | (27.53) | (6.66) | — | (16.04) | (24.17) | (33.86) | (42.95) | (74.67) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (22.87) | (10.90) | (25.44) | — | (4.70) | (10.12) | (7.00) | (6.01) | (4.58) |
Beneish M-Score |
— | — | (2.78) | 0.44 | — | — | (3.31) | (3.58) | 1.41 | (4.29) |
P/B ratio |
— | 4.64 | 3.33 | 2.87 | — | 1.23 | 1.92 | 5.57 | 0.00 | 0.00 |
Price to Tangible BV |
— | 4.64 | 3.33 | 2.87 | — | 1.23 | 1.92 | 5.57 | 0.00 | 0.00 |
EV/Sales |
— | 35.13 | 465.06 | 1,507.87 | — | 19.28 | 45.44 | 75.50 | 46.83 | 40.12 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (4.76) | (1.64) | (4.40) | — | (0.16) | (0.57) | (1.37) | (3.44) | (2.08) |
EV/FCF |
— | (4.68) | (1.63) | (4.36) | — | (0.16) | (0.56) | (1.34) | (3.16) | (2.02) |
Quick Ratio |
5.12 | 3.68 | 3.16 | 6.00 | 5.82 | 8.40 | 7.29 | 6.80 | 0.66 | 0.24 |
Current Ratio |
5.36 | 3.75 | 3.23 | 6.07 | 5.85 | 8.46 | 7.37 | 6.98 | 0.68 | 0.27 |
Net Debt/EBITDA |
1.03 | 0.96 | 0.73 | 1.60 | 0.83 | 0.83 | 0.61 | 0.28 | (0.29) | (0.83) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.42% | 26.18% | 32.76% | 47.56% | 60.79% | 70.55% | 113.45% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.43 | 0.69 | 1.58 | 4.44 | (31.55) | (1.62) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 |
Operating CF/Net income |
0.78 | 0.82 | 0.83 | 0.90 | 0.62 | 0.89 | 0.81 | 0.86 | 0.81 | 0.82 |
Capex/Depreciation |
(0.16) | (0.17) | (0.12) | (0.17) | (0.27) | (0.27) | (0.72) | (1.28) | (5.12) | (1.20) |
Interest Coverage |
(229.66) | (122.21) | (92.29) | (76.76) | (649.01) | (46.89) | (32.32) | (25.59) | (25.40) | (26.76) |
| (81.32%) | (88.93%) | (140.31%) | (74.82%) | (88.06%) | (92.33%) | (119.28%) | (201.67%) | (992.66%) | 260.35% | |
| (66.64%) | (68.31%) | (100.49%) | (60.21%) | (62.70%) | (51.04%) | (47.65%) | (46.25%) | (57.75%) | (74.95%) | |
ROIC |
(488.34%) | 0.00% | 0.00% | (162.36%) | (196.66%) | 0.00% | 0.00% | 0.00% | (257.19%) | (526.92%) |
Return on Tangible Assets |
(90.07%) | (89.58%) | (160.12%) | (67.81%) | (86.94%) | (79.84%) | (77.64%) | (76.40%) | 268.53% | 106.23% |
Average Days of Receivables |
0.00 | 6,183.10 | 9,604.91 | 25,550.00 | 0.00 | 2,060.53 | 670.23 | 38.07 | 64.48 | 31.25 |
Research and Development Expense of Revenue |
0.00% | 45,258.00% | 48,938.89% | 93,813.04% | 0.00% | 10,417.52% | 5,486.06% | 3,817.79% | 961.90% | 1,485.43% |
Selling, General and Administrative Expense of Revenue |
0.00% | 22,386.00% | 16,957.41% | 34,443.48% | 0.00% | 7,457.26% | 4,104.18% | 3,077.91% | 746.93% | 1,013.68% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.23 |
Share Based Compensation of Revenue |
0.00% | 13,096.00% | 9,529.63% | 11,139.13% | 0.00% | 3,807.26% | 1,385.71% | 803.07% | 160.40% | 366.73% |
Graham Net Nets |
— | 0.16 | 0.23 | 0.24 | — | 0.55 | 0.20 | (0.10) | (0.56) | (1.65) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 3.32 | 9.93 |
Earnings Yield |
— | (21.11%) | (48.82%) | (18.12%) | — | (104.88%) | (96.25%) | (69.83%) | (72.49%) | (117.22%) |
Free Cash Flow Yield |
— | (16.41%) | (40.81%) | (16.56%) | — | (92.89%) | (78.84%) | (60.78%) | (63.21%) | (99.20%) |
Revenue per Share |
0.00 | 0.04 | 0.04 | 0.01 | 0.00 | 0.06 | 0.06 | 0.06 | 0.21 | 0.10 |
Operating CF per Share |
(19.77) | (16.15) | (19.11) | (11.59) | (8.80) | (9.07) | (4.99) | (3.44) | (2.87) | (2.01) |
Capex per Share |
(0.32) | (0.26) | (0.15) | (0.12) | (0.11) | (0.07) | (0.06) | (0.06) | (0.26) | (0.06) |
Free Cash Flow per Share |
(20.09) | (16.41) | (19.26) | (11.71) | (8.90) | (9.14) | (5.05) | (3.50) | (3.13) | (2.07) |
Cash per Share |
24.40 | 23.11 | 15.83 | 20.37 | 18.65 | 13.92 | 8.83 | 5.77 | 3.32 | 0.80 |
Shareholders Equity per Share |
27.68 | 21.54 | 14.15 | 24.66 | 16.26 | 8.00 | 3.34 | 1.03 | (0.14) | (1.79) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
27.68 | 21.54 | 14.15 | 24.66 | 16.26 | 8.00 | 3.34 | 1.03 | (0.14) | (1.79) |
Free Cash Flow |
(21.96) | (21.72) | (29.69) | (26.64) | (31.28) | (36.78) | (23.12) | (18.34) | (19.83) | (20.20) |
Working Capital |
23.60 | 23.49 | 18.21 | 40.47 | 55.85 | 50.92 | 35.79 | 26.65 | (10.23) | (23.99) |
Capital Expenditures |
(0.35) | (0.34) | (0.24) | (0.27) | (0.37) | (0.28) | (0.26) | (0.32) | (1.62) | (0.61) |
Net Current Asset Value |
21.73 | 21.58 | 16.88 | 39.03 | 30.98 | 21.87 | 5.91 | (3.00) | (17.45) | (33.58) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 6.84 | 4.43 | 11.74 | 0.00 | 1.20 | 0.91 | 0.99 | 1.21 | 0.61 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.36 | 0.51 | 0.62 | 0.91 | 1.42 | 0.53 | 0.37 | 0.17 | 0.33 |
Cash ROIC |
(38.58%) | (36.76%) | (64.24%) | (25.61%) | (21.25%) | (33.28%) | (28.94%) | (30.74%) | (41.78%) | (108.48%) |
Accounts Receivable Turnover |
0.00 | 0.05 | 0.05 | 0.02 | 0.00 | 0.17 | 0.31 | 1.16 | 9.90 | 6.29 |
Accounts Payable Turnover |
0.52 | 0.00 | 0.00 | 0.38 | 0.36 | 0.29 | 0.00 | 0.00 | 0.33 | 0.25 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
662.10 | 1,146,465.00 | 805,555.00 | 918.08 | 996.16 | 1,222.56 | 118,097.78 | 175,838.75 | 1,174.74 | 1,546.23 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.63 | 0.94 | 1.13 | 1.52 | 1.55 | 1.41 | 0.92 | 0.28 | 0.14 | 0.16 |
Average Payables |
4.18 | 5.12 | 5.35 | 4.18 | 3.84 | 3.63 | 3.22 | 2.42 | 2.06 | 2.29 |
Average Assets |
41.74 | 38.25 | 35.14 | 48.42 | 79.54 | 80.80 | 59.43 | 45.16 | 39.11 | 31.78 |
Average Common Equity |
34.20 | 29.38 | 25.16 | 38.96 | 56.63 | 44.67 | 23.74 | 10.36 | 2.28 | (9.15) |
Columns are period end dates